Somaxon Pharmaceuticals, Inc.
(NASDAQ:SOMX)|
1.28 +0.07 (5.78%) Dec 04 - Close |
|
|
|
After-Hours 1.45 +0.17 (13.28%) Thu, 4 Dec 2008 7:40 PM
- Compare SOMX with:
- View: Line | Candlestick
Company Profile
Somaxon Pharmaceuticals, Inc.
3721 Valley Centre Drive
San Diego, CA 92130
United States - Map
Phone: (858) 480-0400
Fax: (858) 509-1761
Website: www.somaxon.com
State of incorporation: Delaware
CEO: Richard W. Pascoe
Employees: 35
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
A specialty pharmaceutical company.
A pharmaceutical company focused on the in-licensing and development of product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology.
Recent news for SOMX
-
Somaxon Pharmaceuticals to Present at the RBC Capital Markets Healthcare Conference
Business Wire - Yesterday at 8:05 ET
-
EDGAR Online - Dec 02 at 4:57 ET
-
EDGAR Online - Nov 26 at 4:17 ET
-
Somaxon Likely Headed Below $1
Zacks.com - Nov 25 at 1:30 ET
-
FDA extends Somaxon drug review by 3 months
AP - Nov 24 at 10:53 ET
-
UPDATE - FDA extends Somaxon's insomnia drug review by 3 months
Reuters - Nov 24 at 8:40 ET
-
SOMAXON PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
EDGAR Online - Nov 24 at 8:15 ET
-
Briefing.com - Nov 24 at 8:01 ET
-
Business Wire - Nov 24 at 8:00 ET
-
Somaxon Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
Business Wire - Nov 13 at 4:05 ET